WELLINGTON, Fla., Nov. 4 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP), a Wellington, Florida based healthcare organization, announced today that Noel J. Guillama, President & Chief Executive Officer, will be presenting at Paulson Investment's 31st Annual Westergaard Conference on November 12, 2008. Mr. Guillama will be joined by Pete Martinez, Senior Vice President and Chief Technology & Innovations Officer and Ron Smith, Senior Vice President Corporate Development. The Company is scheduled to present at 10:10 a.m., 11:55 a.m., 3:15 p.m., and 5:00 p.m. The conference is being held at the Waldorf Astoria, 301 Park Avenue, New York City, New York.
For additional information or to schedule a one-on-one meeting with The Quantum Group at this conference, please contact Jim Blackman at 713-256-0369 or firstname.lastname@example.org.
About Paulson Capital Corp.
Paulson Capital Corporation is the parent company to Paulson Investment Company, Inc. Headquartered in Portland, Oregon, Paulson Investment Company, Inc. is the Northwest's largest independent brokerage firm and a national leader in public offerings of small and emerging growth companies with capital needs of $5 million to $45 million. Founded by Chester "Chet" Paulson in 1970, it has managed or underwritten 163 securities offerings and has generated more than $1.2 billion for client companies. The firm's enduring success stems from its ability to recognize emerging industry trends and from supporting emerging companies pioneering positive change and advancements in those related markets. Please visit http://www.paulsoninvestment.com.
About The Quantum Group, Inc.
The Quantum Group provides business process solutions, service chain management, strategic consulting and leading edge technology innovations to the healthcare industry.
Through our dynamic patient-centric architecture, we empower the communication that is critical for the coordination of care and take aim at the $600 billion inefficiency gap in the United States healthcare industry. We are guided by a mission to develop efficiencies, improve the quality of patient care and achieve cost reductions for the nation's largest and fastest growing industry.
We have developed leading-edge technology with the creation and deployment of a series of innovative patent-pending initiatives. Through approximately 2,000 healthcare providers and multiple insurance company relationships under management, we are positioned to be a catalyst for change to the Florida healthcare industry.
Certain statements contained in this news release, which are not based
on historical facts, are forward-looking statements as the term is defined
in the Private Securities Litigation Reform Act of 1995, and are subject to
substantial uncertainties and risks in part detailed in the respective
company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K
filings (and amendments thereto) that may cause actual results to
materially differ from projections. Forward-looking statements can be
identified by the use of words such as "expects," "plans," "will," "may,"
"anticipates," "believes," "should," "intends," "estimates" and other words
of similar meaning. These statements are subject to risks and uncertainties
that cannot be predicted or quantified and, consequently, actual results
may differ materially from those expressed or implied by these
forward-looking statements. Such risk factors include, without limitation,
the ability of the Company to properly execute its business model, to raise
substantial and immediate additional capital to implement its business
model, to attract and retain executive, management and operational
personnel, to continue growing its patient base, to negotiate favorable
current debt and future capital raises, to negotiate favorable agreements
with a diversified provider base and to continue to supply the services
needed by its HMO clients as well as physician clients. The Company does
not undertake any obligation to publicly update any forward-looking
statements. There can be no assurance that the provisional patents
discussed in this press release will be granted by the US Patent and
Trademark Office, or, if they are granted, they will not be challenged by
third parties, or if not that we will be able to effectively use or
commercialize such patents and/or we may not have the resources to deploy
such technology. As a result, investors should not place undue reliance on
these forward-looking statements.
FOR MORE INFORMATION, PLEASE CONTACT:
PR Financial Marketing
Jim Blackman: 713-256-0369
The Quantum Group, Inc.
Danielle Amodio: 561.798.9800
|SOURCE The Quantum Group, Inc.|
Copyright©2008 PR Newswire.
All rights reserved